Skip to main content

Day: April 10, 2025

MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Restructuring of Existing Agreements to Remove Corporate Guaranteed Debt by over $1.2 Billion as Well as New Agreements Aimed at Driving Future Growth

MIAMI, April 10, 2025 (GLOBE NEWSWIRE) — MSP Recovery, Inc. (NASDAQ: MSPR) (“MSP Recovery” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, is pleased to announce that it entered into a strategic term sheet (“Term Sheet”) agreeing to several restructuring transactions with Hazel Partners Holdings, LLC (“Hazel”), Virage Capital Management (“Virage”), and their respective affiliates. These initiatives are designed to reduce costs of the Company through a New Servicer entity (as defined below), deleverage the Company by converting certain debt of significant creditors into equity and release $1.2 billion of debt guaranteed by the Company, provide access to $9.75 million of bridge funding to the Company (of which $6.5 million remains available through July 2025)...

Continue reading

Prospera Energy Announces Leadership and Operations Update

CALGARY, Alberta, April 10, 2025 (GLOBE NEWSWIRE) — Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera“, “PEI” or the “Corporation“) Leadership AnnouncementProspera Energy is pleased to announce key appointments to its leadership team, positioning the Company for sustained long term success. Effective immediately, Shubham Garg, who has served as Chairman of the Board since October 2024, will assume the additional role of Interim Chief Executive Officer. Alongside this, Prospera welcomes Mr. Christopher Moore to its Board of Directors. A seasoned entrepreneur and investor, Mr. Moore is a prominent shareholder of the Corporation and brings a formidable blend of industry expertise and market insight. Prospera’s five-member Board now collectively owns 13% of the Company’s outstanding common equity, while...

Continue reading

Titan Acquisition Corp Announces Closing of $276,000,000 Initial Public Offering

BROOKLYN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) — Titan Acquisition Corp (Nasdaq: TACHU) (the “Company”) today announced that it closed its initial public offering of 27,600,000 units at $10.00 per unit, including the issuance of 3,600,000 units as result of the underwriters’ exercise of its over-allotment option in full. The gross proceeds from the offering were $276 million before deducting underwriting discounts and estimated offering expenses. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “TACHU” on April 9, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Once the securities comprising the units begin separate trading,...

Continue reading

Immuron Travelan® highest sales in history

Sales Highlights (unaudited):GlobalImmuron exceeds AUD$5 million in sales in a fiscal year – highest sales in history March 2025 Quarter AUD$1.3 million up 2% on prior year March 2025 Year to Date AUD$5.3 million up 46% on prior yearAustraliaMarch 2025 Quarter AUD$0.8 million down 8% on prior year March 2025 Year to Date AUD$3.7 million up 34% on prior yearNorth AmericaMarch 2025 Quarter AUD$0.5 million up 28% on prior year March 2025 Year to Date AUD$1.6 million up 86% on prior yearMELBOURNE, Australia, April 10, 2025 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce continued sales growth (unaudited) of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and...

Continue reading

Currency Exchange International, Corp. Announces Referral Agreement with Continental Currency Exchange

Exchange Bank of Canada (“EBC” or the “Bank”) is to refer its wholesale business-to-business (B2B) banknote customers in Canada to Continental Currency Exchange, Ltd. (“CCE”), a wholly owned subsidiary of DUCA Financial Services Credit Union Ltd. (“DUCA”)TORONTO, April 10, 2025 (GLOBE NEWSWIRE) — Currency Exchange International, Corp. (“CXI” or the “Company”) (TSX:CXI) (OTC:CURN), today announced a referral agreement has been entered into with CCE, one of Canada’s leading retailers of foreign exchange services. CCE operates 19 branch locations across Ontario and offers digital products, foreign exchange conversion services, pre-authorized debit and deposit transactions, foreign cheques and drafts, money transfers and wire payments in over 120 currencies. CCE is a wholly owned subsidiary of DUCA, which was formed in 1954...

Continue reading

Hut 8 Schedules First Quarter 2025 Earnings Release and Conference Call

MIAMI, April 10, 2025 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), an energy infrastructure platform integrating power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases such as Bitcoin mining and high-performance computing, today announced it will release financial results for the first quarter of 2025 before the market opens on May 8, 2025. The Company will host a conference call and webcast to review the results on the same day at 8:30 a.m. ET. Conference Call and Webcast Details Date: Thursday, May 8, 2025Time: 8:30 a.m. ET Investors can join the live webcast here. Analysts can register here. Supplemental Materials and Upcoming Communications The Company expects to make available on its website materials designed to accompany the discussion of...

Continue reading

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for when and where to receive treatment – at home, while ‘on the go’ or in a healthcare setting Approval reflects commitment to innovating the patient experience with individualized, safe and effective therapiesApril 10, 2025, 11:45 PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) approved a new option for patients to self-inject VYVGART® Hytrulo with a prefilled syringe (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of...

Continue reading

PCS Edventures! Announces 10 Million Share Repurchase Authorization

BOISE, Idaho, April 10, 2025 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (“PCSV”), a leading provider of K-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced that its Board of Directors has authorized a share repurchase program to repurchase up to 10 million shares of its common stock over the next three years. This represents approximately 8.18% of PCSV’s shares outstanding as of December 31, 2024. Under the new authorization, the Company may repurchase shares from time to time through a variety of methods, including open market purchases and privately negotiated transactions. All repurchases will be conducted in accordance with applicable securities laws, including Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934, as amended, and other relevant regulations. The repurchase...

Continue reading

NewHold Investment Corp III Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 17, 2025

New York, New York, April 10, 2025 (GLOBE NEWSWIRE) — NewHold Investment Corp III (the “Company”) announced today that, commencing April 17, 2025, holders of the units sold in the Company’s initial public offering completed on March 3, 2025 may elect to separately trade the Class A ordinary shares (the “Ordinary Shares”) of the Company and the warrants included in such units on The Nasdaq Global Market (“Nasdaq”). The Ordinary Shares and warrants that are separated will trade on Nasdaq under the symbols “NHIC” and “NHICW,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “NHICU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Ordinary Shares and warrants. The...

Continue reading

Targa Resources Corp. Declares Increase to Quarterly Common Dividend and Announces Timing of First Quarter 2025 Earnings Webcast

HOUSTON, April 10, 2025 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that its board of directors has declared an increase to its quarterly cash dividend to $1.00 per common share, or $4.00 per common share on an annualized basis, for the first quarter of 2025, consistent with previously disclosed expectations. This dividend represents a 33 percent increase over the common dividend declared with respect to the first quarter of 2024. This cash dividend will be paid May 15, 2025 on all outstanding common shares to holders of record as of the close of business on April 30, 2025. The Company will report its first quarter 2025 financial results before the market opens for trading on Thursday, May 1, 2025, and will host a live webcast over the internet at 11:00...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.